Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$5.35 - $6.35 $1,070 - $1,270
-200 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$5.68 - $7.87 $1,136 - $1,574
200 New
200 $1,000
Q4 2020

Feb 16, 2021

SELL
$5.25 - $8.56 $183,750 - $299,600
-35,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$5.78 - $7.47 $202,300 - $261,450
35,000 New
35,000 $219,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.